TGFB1 and hepatocellular carcinoma: These data further verified that ELF and TGF-β1 were important and promising candidate tumor biomarker for predicting the prognosis of patients with HCC, and we hypothesized if combination of ELF and TGF-β1 could give us a more sensitive way to predict HCC patients’ outcome.